Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05581082 · ClinicalTrials.gov registry record
Understanding Changes in Physical Function Using Principles of Precision Medicine
A clinical trial of Frailty, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 18
- Enrollment target
- 1
- Study location
NCT05581082: Completed study of Frailty, sponsored by University of North Carolina, Chapel Hill.
NCT05581082 is a study of Frailty that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 18 participants, below the 1,506-participant average among 48 other Frailty trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05581082, a study of Frailty, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot, feasibility study and the purpose of this study is exploratory. The goal is to provide the PI and study team with data using metabolomics that can be used to: a) demonstrate an ability to use such data in a future grant application; b) obtain data that determines the relationship between changes in physical function (objective and subjective) and potential metabolites.
Primary Outcome
The team will collect a blood sample at baseline (0- weeks) and follow-up (12-weeks) to conduct an untargeted metabolomic analysis to demonstrate potential peaks of protein within the blood reported in mg/dL.
Conditions Studied
Interventions
- OTHER Pragmatic, exploratory study of Precision Medicine
Study Locations (1)
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2022-07-30 |
| Est. Completion | 2023-09-30 |
What the finished NCT05581082 record still lists
NCT05581082 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,506-participant average among 48 other Frailty trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Frailty appearing as the primary indexed condition, and to 1 intervention - of which Pragmatic, exploratory study of Precision Medicine is the first listed.
NCT05581082 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05581082 about?
NCT05581082 is a clinical study titled "Understanding Changes in Physical Function Using Principles of Precision Medicine". This is a pilot, feasibility study and the purpose of this study is exploratory. The goal is to provide the PI and study team with data using metabolomics that can be used to: a) demonstrate an ability to use such data in a future grant application; b) obtain data that determines the relationship be...
What is the current status of trial NCT05581082?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2022-07-30. Estimated completion is 2023-09-30.
What conditions does trial NCT05581082 study?
This clinical trial studies the following conditions: Frailty.
What interventions are being tested in trial NCT05581082?
The interventions under investigation include: Pragmatic, exploratory study of Precision Medicine (OTHER).
Who is sponsoring clinical trial NCT05581082?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05581082 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Frailty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05581082's enrollment target sits among peer trials
18 45th of 48 higher than 4 of 48 other Frailty trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Frailty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Physical Ability and Cellular Senescence Elimination in HIV
RECRUITING · Phase 2
-
Reducing Frailty for Older Cancer Survivors Using Supplements II
RECRUITING · Phase 2
-
A Partnered Evaluation to Improve the Identification and Management of Functional Impairment and Frailty Among Older Veterans in Primary Care Settings
RECRUITING · NA
-
Occupational Therapy and Registered Dietitian Services to Reduce Fall Risk Among Home Delivered Meal Clients
RECRUITING · NA
-
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
RECRUITING · Phase 2
-
Evaluation of the Walk With Ease Program for Fall Prevention
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI